Microsoft's CTO testifies about email at the heart of Elon Musk’s allegations against the tech giant

Microsoft testified it has committed $13 billion to OpenAI and that total OpenAI-related spending, including infrastructure and hosting, is now 'upwards of $100 billion,' while direct revenue through March 2025 was about $9.5 billion. The trial centered on Elon Musk’s claims that Microsoft knew OpenAI was abandoning its nonprofit mission and effectively controlled the for-profit conversion; closing arguments are set for Thursday, with jury deliberations expected Monday. The latest testimony also highlighted Microsoft’s evolving deal terms with OpenAI, including a roughly 27% stake, a $250 billion Azure spending commitment, and a non-exclusive cloud arrangement through 2032.

Analysis

The market-relevant issue is not the courtroom optics; it is whether this litigation becomes a slow-burn governance overhang for MSFT’s AI monetization stack. The facts as aired make a clean bifurcation: near-term revenue is largely insulated, but the asset being tested is Microsoft’s right to keep converting OpenAI proximity into cloud share, model access, and distribution leverage without a control discount.

The bigger second-order risk is that any adverse finding increases scrutiny on how “non-control” minority investments with operational vetoes are structured across AI private markets. That would matter beyond this case: it could force more conservative terms in frontier-model financings, reduce the value of strategic capital, and marginally slow hyperscaler deal velocity just as capex competition is intensifying. Google is the relative beneficiary in the sense that any legal noise around Microsoft/OpenAI narrows the gap in enterprise AI credibility if buyers begin diversifying cloud commitments sooner.

For MSFT, the equity is likely to trade the legal headline as a multiple issue, not an earnings issue. The upside case is that the renegotiated terms and expanded non-exclusivity already de-risk the most aggressive antitrust-style interpretation; the downside case is a finding that Microsoft’s influence was functionally control, which could increase the chance of remedies, disclosure burdens, or even tougher treatment of future AI investments over the next 6-18 months. TSLA is only indirectly exposed here, but Musk’s willingness to litigate means the stock can still see periodic volatility spikes around verdict odds rather than fundamental changes.

The contrarian view is that consensus may be overestimating damage to MSFT and underestimating the strategic value of having secured frontier-model optionality early. Even if legal costs rise, the economic moat from embedded distribution and Azure workload learning is already largely sunk; the real question is whether that moat gets fully repriced in the stock. On the other side, GOOGL’s relative AI positioning could improve if enterprise buyers want a second-source hedge, but that is more a share-of-wallet shift than a sudden earnings inflection.

Key Decisions for Investors

• Maintain a modest long MSFT / short GOOGL relative-value pair for 1-3 months into verdict resolution: if MSFT escapes with limited remedies, the stock should re-rate back toward AI monetization optionality, while GOOGL has less direct downside but also less idiosyncratic upside from this case.
• Buy short-dated MSFT downside hedges into the verdict window: 1-2 month put spreads financed by selling farther OTM puts, targeting a limited legal-event drawdown rather than a fundamental earnings break.
• If the jury appears hostile on control/governance, rotate from MSFT common into MSFT call spreads or synthetic long exposure after the first post-verdict selloff; the market is likely to over-discount the probability of business disruption versus remedy risk.
• Avoid outright long TSLA on the case itself; use only event-driven options if you want Musk-volatility exposure, because the legal outcome is more likely to create headline gamma than durable P&L revision.
• For multi-strategy books, consider a basket long of AI infrastructure beneficiaries with less litigation overhang than MSFT/OpenAI-adjacent names, funded by trimming strategic-hypercaler exposure until the remedy risk clears.